The Pioneering Advocacy of A4LI in Longevity Biotechnology A4LI pioneers in longevity biotechnology advocacy, promoting policies to extend healthy lifespans and transform aging into a treatable condition May 31, 2024 Lifestyle·Politics·Science·Technology
Seragon Biosciences’ RESTORIN: A Breakthrough in Targeting Multiple Longevity Pathways September 25, 2024 RESTORIN activates key longevity pathways like DNA repair, mTOR inhibition,
Longevity Dividend: What You Need to Know September 19, 2024 Scientists are unlocking the secrets of aging, aiming to extend
Seragon’s SRN-901: Breakthrough Aging Intervention Drug Achieves Dramatic Lifespan Extension in Preclinical Study September 19, 2024 In a May 7, 2024 press release, Seragon Biosciences announced
Aging Reversed: Are People Already Using Longevity Therapies? September 18, 2024 Anti-aging breakthroughs in gene therapy and AI-driven drug discovery promise